Levosalbutamol & Ipratropium Bromide Inhalation – Brizium Plus Inhaler

Levosalbutamol & Ipratropium Bromide Inhalation – Dual Bronchodilation for Effective Respiratory Relief

Brizium Plus Inhaler: The Dual combination of Levosalbutamol 50mcg + Ipratropium Bromide 20mcg is provide faster and longer-lasting respiratory relief in obstructive airway diseases.
Levosalbutamol stimulates β2 receptors, relaxing bronchial smooth muscles and providing rapid relief from bronchospasm. Ipratropium blocks muscarinic receptors, reducing mucus secretion and preventing bronchial constriction.

Recommended bY Specialists:
Pulmonologists : It is mainly used to prefer this combination to treat the disease associated for managing COPD, asthma, and other obstructive airway diseases.
General Physicians; It is mainly used to treat the disease associated with treating acute bronchospasm or mild/moderate asthma symptoms.

Key Benefits of Levosalbutamol & Ipratropium Bromide Inhalation – Brizium Plus Inhaler
Dual Bronchodilator Action – Levosalbutamol offers rapid β2 agonist bronchodilation, while Ipratropium provides anticholinergic bronchodilation for enhanced airflow and symptom relief.
Superior Control in Acute Exacerbations – Ideal for managing acute bronchospasm and COPD exacerbations by targeting different pathways of airway constriction.
Minimal Systemic Side Effects – Localized nebulization reduces systemic absorption, ensuring effective relief with a good safety profile, especially in elderly and pediatric patients.

INDICATIONS:
Acute Bronchospasm
Chronic Obstructive Pulmonary Disease (COPD)
Bronchial Asthma
Acute Exacerbations of Chronic Bronchitis